::
18 Diciembre 2025 / 17:00 CET
Food biotech has the potential to unlock Food as Medicine, especially through advances in microbiome science. Yet turning complex research into real, scalable solutions remains one of the sector’s greatest challenges.
This coming Thursday, the 18th, we launch the Gut4U OpenTalks with Soledad Gurovic, founder of Future Biome.
Food biotech holds immense potential to unlock Food as Medicine, particularly through advances in microbiome science. Yet translating complex research into real-world solutions remains one of the greatest challenges.
In this live conversation, I’ll be joined by Soledad Gurovic, founder of Future Biome, a startup developing precision, fungi-based prebiotic ingredients designed to support gut and overall health by optimizing the microbiome.
In this conversation, we’ll explore:
- The gap between microbiome research and scalable products, and the reality of navigating the early-stage “valley of death”
- How startups, industry, and regulatory bodies operate amid scientific uncertainty
- Why progress depends not only on innovation, but on investors who truly understand the science, risk, and problem being solved
- The role of consumers, and how expectations, education, and trust will shape the future of microbiome-driven Food as Medicine
🕔 17:00 CET (España)
🕔 8:00 AM PT (US West Coast)
🕔 10:00 AM CST (Mexico)
🕔 1:00 PM ART (Argentina)